LRRN1 and neoplasm: Additionally, LRRN1 may activate γδ T cells and resting dendritic cells, regulate the M1/M2 macrophage balance in the tumor microenvironment (p<0.001), and mediate the efficacy of certain tyrosine kinase inhibitors (TKIs) (p<0.001).